Rishabh Singh, MD1, Jacob Cogan, MD2, Caroline Cromwell, MD3, Manila Gaddh, MD4, Radhika Gangaraju, MD5, Ming Y Lim, MBBChir6, Colleen T. Morton, MD7, Andrew M. Peseski, DO8, Rachel P. Rosovsky, MD9, Ishan J Tatake, MD10, Kimberley Youkhana, MD, MSCR11 and Lisa Baumann Kreuziger, MD, MS12,13
1Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, IL
2Classical Hematology, University of Minnesota, Minneapolis, MN
3Icahn School of Medicine, Hematology and Medical Oncology, Mount Sinai, New York, NY
4Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
5Division of Hematology and Oncology, Department of Medicine, University Of Alabama at Birmingham, Birmingham, AL
6Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah Health, Salt Lake Cty, UT
7Vanderbilt, Nashville, TN
8Division of Hematology, Duke University Medical Center, Durham, NC
9Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
10Department of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Brookline, MA
11Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC
12Versiti, Milwaukee, WI
13Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee